FDA’s Opdivo Lung Cancer Approval

By João L. Carapinha

October 11, 2024

The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
Enhancing Global Health through Regulatory Collaboration
Mental Health Trends Among US Youths: Rising Prevalence of Depression and Anx...
Created and Validated by FDA: AI Drug Safety Surveillance Tool
Understanding the Impact of COVID-19 on Youth Mental Health
Cost-Effectiveness of Integrated Care for Children with Chronic Conditions
Eli Lilly’s Alzheimer’s Drug Kisunla Gains Approval in Japan
The Readiness of Biosimilars in Multiple Sclerosis Treatment
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
In Saudi Arabia, the Hevolution Foundation is Reshaping Ageing Research
Pharmacogenetic Screening: A Cost-Effective Strategy in Treating Major Depres...
NICE Recommends Abaloparatide for Osteoporosis in the Elderly
Elderly Technology Acceptance: Enhancing Health and Independence